HMH Carries a Thin IPO Week Across the Line

HMH was the week’s only real handoff from filing work to public trading. The offshore drilling equipment supplier priced 10.52 million Class A shares at $20, inside its $19 to $22 range, raised $210.4 million in gross proceeds, and began trading on the Nasdaq Global Select Market on April 1 under the ticker HMH.

That was enough to give the week a center of gravity, but not enough to call it a hot tape. HMH indicated below issue on debut and closed its offering on April 2 with roughly $193.8 million of net proceeds after underwriting discounts, commissions, and estimated expenses. The deal worked in the mechanical sense: SEC effectiveness, final prospectus, trading, closing. It did not deliver the kind of first-day demand signal that pulls marginal issuers forward.

The useful read is narrower. Investors were willing to fund a conventional industrial issuer with real scale, an energy-services cycle exposure, and a bank group led by J.P. Morgan, Piper Sandler, and Evercore ISI. They were not willing to pay through the range for it. In a calendar otherwise dominated by amendments, SPAC paper, and small-cap cleanup, that distinction mattered.

HMH Gives the Week Its Price

HMH is not a software-style growth story hiding in an energy wrapper. It provides drilling equipment, services, and systems for offshore and onshore oil and gas operations, with aftermarket work and some exposure to adjacent markets such as mining. The company came public through an Up-C structure, with a portion of proceeds used to acquire voting shares from Baker Hughes and Akastor.

The structure and use of proceeds make this a slightly more complex read than the headline deal size suggests. The IPO brought new public float and liquidity, but it also sat alongside a reorganization involving large legacy holders. The underwriters also have a 30-day option to buy up to 1.578 million additional shares at the IPO price, less underwriting discounts and commissions.

For the market, the cleaner point is pricing discipline. HMH cleared inside the range, not at the top. It had a credible bookrunner lineup and a business that public investors can benchmark against energy-services peers, yet the early trade still leaned below issue. That is a workable IPO, not an emphatic one.

Elmet Adds a More Strategic Industrial File

The more interesting new industrial candidate was The Elmet Group, which filed for a proposed Nasdaq listing under the symbol ELMT. Elmet makes precision-engineered components and high-energy systems tied to critical materials such as tungsten, molybdenum, and niobium, with end markets including aerospace and defense, industrial, medical, semiconductor and electronics, and energy.

The filing has the right thematic hooks: U.S. manufacturing capacity, strategic materials, defense-adjacent demand, and advanced RF and high-power microwave systems. It also has a stronger underwriting roster than the typical small industrial filing, with Cantor, Needham, Canaccord Genuity, and Roth Capital Partners listed.

What it does not yet have is the part that lets investors judge demand: no share count, no range, and no gross proceeds target. The filing added details around underwriting economics, including broker warrants, and pro forma adjustments tied to debt settlements, stock-based compensation, and IPO proceeds. Until terms arrive, Elmet is a higher-quality setup rather than a deal investors can price.

Churchill Keeps SPAC Supply Alive

Churchill Capital Corp XII filed for a $300 million SPAC IPO, offering 30 million units at $10 each and seeking a Nasdaq listing under CXIIU. The filing gives Michael Klein’s Churchill platform another vehicle at a time when blank-check issuance is more selective than it was in the last cycle, but still not gone.

The signal is not that SPAC demand has broadly reset. It is that recognized sponsors can still test the market with institutional-sized vehicles. Churchill XII has the familiar structure: public units, founder shares, private placement securities, redemption rights, and a 24-month combination window that can extend to 27 months. For IPO investors, it belongs in the week because it was sizeable and newly filed, but it is a different risk from an operating-company debut.

CoinShares Was a Listing Event, Not a Fresh IPO

CoinShares also reached Nasdaq during the week, but through a completed business combination rather than a traditional underwritten IPO. The company began trading on April 1 under CSHR after combining with Vine Hill Capital Investment Corp. and a newly formed holding company, CoinShares PLC.

The public listing gives U.S. investors another digital-asset manager to watch. CoinShares said the transaction valued the company at about $1.2 billion pre-money and was anchored by a $50 million institutional common equity commitment. It also described itself as managing more than $6 billion in assets and holding a leading position in European crypto ETPs.

That is relevant market context, but it should not be mixed with the read-through from HMH. CoinShares was a de-SPAC/listing event with crypto beta and transaction-specific mechanics. HMH was the only operating-company IPO in the week that priced, opened, and closed in the conventional way.

The Small-Cap Lane Stayed Busy

The rest of the week was mostly amendment work. Student Living EduVation updated its F-1 for a proposed Nasdaq Capital Market listing under SDLV, with a $4 to $6 indicated range, 3.75 million primary shares, and a resale component covering 5.88 million shares. The company is a Cayman Islands holding company with operations through a Hong Kong subsidiary, and the most useful caution is scale: recent filing data showed less than $1 million of revenue.

Micware also amended its F-1, keeping a proposed 3.75 million ADS offering at a $7 to $9 range. The filing incorporated a 241-for-1 share split effective March 31 and revised underwriting terms with A.G.P. The terms point to a roughly $30 million midpoint deal, but the operating base is thin enough that the amendment is more cleanup than a broad market signal.

Aardvark Therapeutics and Wetour Robotics should be read similarly narrowly. Aardvark’s effectiveness notice related to a registration statement after its earlier public-market entry, not a new weekly IPO. Wetour’s effectiveness followed its transition from Webus International and a shelf-registration path. Both are relevant for corporate-finance tracking, but neither changes the week’s IPO temperature.

The Close

The week mattered because one real issuer got through and several others moved closer, not because the market suddenly opened. HMH proved that a mid-sized industrial deal can still clear with a strong banking syndicate and a price inside range. Elmet added a more strategic industrial story that could become important once terms arrive. Churchill showed that sponsor-led SPAC supply still has pockets of life.

That leaves the calendar constructive but selective. Investors are still asking issuers to show size, comparability, and disciplined pricing. HMH met that bar just well enough. The next test is whether the amendment-heavy names can turn paperwork into executable terms without leaning on novelty or microcap scarcity.